Keywords: zyprexa, gains, 1st, approvals, usa/eu, schizophrenia, eli

Zyprexa Gains 1st Approvals In USA/EU For Schizophrenia

Article | 07 October 1996

Print This

Eli Lilly has been granted approval in the USA and European Union for its new "atypical" antipsychotic agent Zyprexa (olanzapine). ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in